Diet for preventing cardiovascular diseases: Light from Ancel Keys, Distinguished Centenarian Scientist

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 14, Issue 1, 2004, Pages 52-57

  Mancini, M ^a   Stamler, J ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Body weight; Cardiovascular disease; Cholesterol; Dietary fat; Mediterranean diet

Indexed keywords

CHOLESTEROL; FAT; POLYUNSATURATED FATTY ACID;

ACADEMIC ACHIEVEMENT; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIETARY INTAKE; FAT INTAKE; HUMAN; MEDICAL PROFESSION; OBESITY; PREDICTION; REVIEW; SCIENCE; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

EID: 2342507774     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(04)80047-4     Document Type: Article

References (55)

1. Mancini M (1954) The transfer of lipids in plasma: pathophysiological implications. M.D. Thesis, Faculty of Medicine, University of Naples
2. Katz LN, Stamler J (1953) Experimental Atherosclerosis, Charles C. Thomas, Springfield, Ill.
3. Bronte Stuart B, Heptinstall RH (1954) The relationship between experimental hypertension and cholesterol induced atheroma in rabbits. J Pathol Bact 68; 407
4. Morgan AD (1956) The pathogenesis of coronary occlusion. Blackwell Scientific Publications, Oxford
5. Heptinstall RH, Barkley H, Porter KA (1958) Relative role of blood cholesterol and blood pressure level in the production of experimental atheroma in rabbits. Angiology 9; 84
6. Keys A (1993) The inception and pilot surveys. In: Kromhout D, Menotti A, Blackburn H (eds), The Seven Countries Study, Brower, Utrecht
7. Keys A, Aravanis C, Blackburn HW (1967) Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand 460 (Suppl. 180): 1-392
8. Fidanza F, Menotti A (1993) Studies in rural Italy. In: Kromhout D, Menotti A, Blackburn H (eds), The Seven Countries Study. Brower, Utrecht
9. Keys A, Keys M (1959) Eat well and stay well. Doubleday N.Y.
10. Keys A, Keys M (1975) How to eat well and stay well the Mediterranean way. Doubleday, N.Y.
11. Keys A (1970) Coronary Heart Disease in Seven Countries. Circulation 41 (Suppl. 1): 1-211
12. Keys A, et al (1980) Seven Countries. A multivariate analysis of death and coronary heart disease. A Commonwealth Fund Book, Harvard University Press, Cambridge Mass and London
13. Keys A, Anderson JT, Grande F (1965) Serum cholesterol response to changes in the diet. (I-IV) 14: 747-758, 759-765, 766-775, 776-787.
14. Anderson JT, Lawer A, Keys A (1957) Weight gain from simple overeating. Serum lipids and blood volume. J Clin Invest 36: 81-88
15. Keys A, Grande F, Anderson JT (1961) Fiber and pectin in the diet and serum cholesterol concentration in man. Proc. Soc. Exp. Biol. Med. 106: 555-562
16. Inter-Society Commission for Heart Disease Resources, Atherosclerosis Study Group and Epidemiology Study Group (1970) Primary prevention of the atherosclerotic diseases. Circulation 42: A55-A95
17. Maseri A (1997) Inflammation, atherosclerosis, and ischemic events. Exploring the hidden side of the moon. N. Engl. J. Med. 336, 1014-1015
18. Nygard O, Nordrehaug JE, Refsum H, Ubland PM, Parstad M, Vollset SM (1997) Plasma homocysteine and mortality in patients with coronary heart disease. N Engl J Med 337: 230-236
19. Ridker PM, Cushman M, Stampfer MJ, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979
20. Ridker PM, Hennekens CH, Buring JF, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843
21. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959-1965
22. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143
23. Blackburn H (2001) If it isn't fun. Lynn Marasco Ed. Canada, p. 328
24. Hulley SB, Newman TB, Jacobs DR (1994) Toward a more balanced cholesterol policy. Circulation 1994, 90: 2570-2572
25. Stamler J, Wentworth D, Neaton JD (1986) Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828
26. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Greenland P, Liu K (1999) Low risk factor profile and long term cardiovascular and non-cardiovascular mortality and life expectancy: findings from five large cohort of young adult and middle-aged men and women. JAMA 282: 2012-2018
27. Greenland P, Deloria Knoll M, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW (2003) Major risk factors as antecedents of fatal and non fatal coronary heart disease events. JAMA 290: 891-897
28. Virchow R (1856) Phlogose und Thrombose in Gefassystem. In: Meidinger Sohn, Frankfurt
29. Ross R, Harker L (1976) Hyperlipidemia and atherosclerosis. Science, 1094-1100
30. Ross R (1996) The pathogenesis of atherosclerosis. An update. N Engl J Med 314: 488
31. McGill HC Jr, McMahan CA (1998) Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol 82 (10B) 30T-36T
32. McGill HC Jr, McMahan CA, Zieske AW, et al (2000) Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 102: 374-379
33. Holman RL, Mc Gill HC, Strong JP, Geer JC (1958) Natural history of atherosclerosis. Am J Pathol 34: 209-235
34. van der Meer IM, Iglesias del Sol A, Hak AE, Bots ML, Hofman A, Witteman JC. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke (2003) 34: 2374-2379
35. Mitchell JRA, Schwartz CI (1965) Arterial Disease. Blackwell Scientific Publ., Oxford
36. Lewis B, Assmann G, Tikkanen M, Mancini M, Pometta D, for The International Task Force for Prevention of Coronary Heart Disease (1992) Prevention of Coronary Heart Disease. Scientific background and New Clinical Guidelines. Nutr Metab Cardiovasc Dis 2: 113-156
37. Saikku P, Leinonen M, Tenkanen L, et al (1992) Chronic chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116: 273-278
38. Gurginkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B (1999) Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J 20: 121-127
39. Mancini M (2002) Health effects of nutritional transition and lifestyle changes in developing countries: the Chinese experience. Nutr Metab Cardiovasc Dis 12: 110-111
40. Li YH, Li Y, Davis CE, et al (2002) Serum cholesterol changes from 1983-1984 to 1993-1994 in the People's Republic of China. Nutr Metab Cardiovasc Dis 12: 118-126
41. The Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
42. Shepherd J, Cobbe SM, Ford I, et al for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307
43. Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesterol and Recurrent Event Trial Investigators. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 35: 1001-1009
44. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349-1357
45. Downs JR, Clearfield M, Weis S, et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/Tex-CAPS. JAMA 279: 1615-1622
46. Heart Protection Study Collaborative Group (2002) Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22
47. Katz LN, Stamler J, Pick R (1958) Nutrition and Atherosclerosis. Lea and Febiger, Philadelphia
48. National Cholesterol Education Program (1994) Second report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 89: 1329-1445
49. Pyörälä K, De Backer G, Poole-Wilson P, Wood D, on behalf of the Task Force (1994) Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 15: 1300-1331
50. Assmann G, Carmena R, Cullen P, J-C Fruchart, Lewis B, Mancini M, et al for The International Task Force for Prevention of Coronary Heart Disease. (1998) Coronary heart disease: reducing the risk. Nutr Metab Cardiovasc Dis 8: 205-271
51. Wood D, De Backer G, Faegerman O, Graham I, Mancia G, Pyörälä K, and the Members of the Task Force (1998) Recommendation of the Second Joint Task Force of the European and other Societies on Coronary Prevention. Eur Heart J 19: 1434-1503
52. Menotti A, Lanti M, Puddu PE, Carratelli L, Mancini M, Motolese M, Prati P, Zanchetti A. (2002) The risk functions incorporated in Riscard 2002: a software for the prediction of cardiovascular risk in general population based on Italian data. Ital Heart J 3: 114-121
53. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2494
54. Keys A (1995) Mediterranean diet and public health: personal reflexions. Am J Clin Nutr 61: 1321s-1323s
55. Jiménez FP, Miranda JL, Mata P (2002) Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis 163: 385-398